CAS 1276105-89-5

CNX-1351

Description:

As of my last update in October 2023, CNX-1351, with the CAS number 1276105-89-5, is a chemical compound that has garnered interest in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as molecular structure, physical properties, and detailed biological activity may not be widely documented in public databases, compounds like CNX-1351 are typically evaluated for their solubility, stability, and reactivity under various conditions. In the context of drug development, such substances are often assessed for their pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME), as well as their efficacy and safety profiles in biological systems. Researchers may also investigate the compound's mechanism of action, potential side effects, and interactions with other molecules. For precise and updated information, consulting specialized scientific literature or databases is recommended, as ongoing research may yield new insights into the characteristics and applications of CNX-1351.

Formula: C₃₀H₃₅N₇O₃S

Synonyms:

• CNX-1351
• 1-[4-[[2-(1H-Indazol-4-yl)-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]-1-piperazinyl]-6-methyl-5-heptene-1,4-dione
• 1-[4-[[2-(1H-Indazol-4-yl)-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]-1-piperazinyl]-6-methyl-5-heptene-1,4-dione CNX1351
• CNX-1351; CNX 1351; CNX1351
• CS-1069
• 1-(4-((2-(1H-indazol-4-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-6-methylhept-5-ene-1,4-dione
• CNX-1351, >=98%

CNX-1351

CAS: 1276105-89-5

CNX-1351

Purity: ≥98%

Molecular weight: 573.71g/mol

Ref: 54-BUP08107

CNX-1351

CAS: 1276105-89-5

CNX-1351 is a potent and isoform-selective targeted covalent PI3Kα inhibitor.

Formula: C₃₀H₃₅N₇O₃S

Purity: 99.66% - 99.83%

Color and Shape: Solid

Molecular weight: 573.71

Ref: TM-T2256

CNX-1351

CAS: 1276105-89-5

CNX-1351 is a small molecule that inhibits the protein gene of viruses. It also has an antiproliferative effect on cancer cells, which is due to its ability to inhibit cell growth and induce apoptosis. CNX-1351 is synthesized by attaching a lipid kinase inhibitor and phosphoinositide mimetic to a potent death protein. This synthetic compound potently induces cancer cell death, which may be due to inhibition of signal transduction pathways and the inhibition of lipid kinase activity in the cancer cell membrane.

Formula: C₃₀H₃₅N₇O₃S

Purity: Min. 95%

Molecular weight: 573.71 g/mol

Ref: 3D-BBC10589